Ligand Pharmaceuticals' IPO

Ligand Pharmaceuticals raised a round of funding on October 08, 1992. Investors include Public.

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, inflammatory diseases, …

Articles about Ligand Pharmaceuticals' IPO: